- Revenue for Q4 FY19 of INR 2,579 Million, a growth of 16% (y-o-y)
- and for FY19 of INR 9,787 Million, a growth of 18% (y-o-y)
- EBITDA for Q4 FY19 at INR 354 Million, a growth of 2% (y-o-y)
and for FY19 of INR 1,326 Million, a growth of 1% (y-o-y)
Bengaluru, May 26, 2019: HealthCare Global Enterprises Limited (“HCG”) today announced its financial results for the quarter (“Q4 FY19”) and fiscal year (“FY19”) ended March 31, 2019.
Highlights for quarter ended March 31st, 2019
- Consolidated Income from Operations (“Revenue”) was INR 2,579 mn as compared to INR 2,223 mn in the corresponding quarter of the previous year, reflecting a year-on-year increase of 16.0%.
- Consolidated Profit Before Depreciation and Amortization, Finance Costs, Exceptional Items and Taxes (“EBITDA”) was INR 354 mn as compared to INR 348 mn in the previous year in the corresponding quarter of the previous year.
Highlights for year ended March 31st, 2019
- Consolidated Income from Operations (“Revenue”) was INR 9,787 mn as compared to INR 8,307 mn in the previous year, reflecting a year-on-year increase of17.8%.
- Consolidated Profit Before Other Income, Depreciation and Amortization, Finance Costs, Exceptional Items and Taxes (“Operating EBITDA”) was INR 1,252 mn as compared to INR 1,188 mn in the previous year.
- Operating EBITDA loss from new centers was INR 140 mn as compared to a loss of INR 90 mn in the previous year.
- Consolidated Profit after Taxes and Minority Interest (“PAT”)(4) was a loss of INR 248 mn as compared to a profit of INR 205 mn in the corresponding quarter of the previous year.
Corporate Comm India(CCI Newswire)
